OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

OM-85 Broncho-Vaxom®, a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells
Lei Fang, Liang Zhou, Michael Tamm, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1544-1544
Open Access | Times Cited: 17

Showing 17 citing articles:

Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19
Duoduo Zha, Mingui Fu, Yisong Qian
Cells (2022) Vol. 11, Iss. 12, pp. 1972-1972
Open Access | Times Cited: 33

Immunological Insights and Therapeutic Advances in COPD: Exploring Oral Bacterial Vaccines for Immune Modulation and Clinical Improvement
Sławomir Lewicki, Barbara J. Bałan, Marta Stelmasiak, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 107-107
Open Access

Modulation of innate immunity in airway epithelium for host-directed therapy
Iwona T. Myszor, Guðmundur H. Guðmundsson
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12

Secretory IgA and course of COVID-19 in patients receiving a bacteria-based immunostimulant agent in addition to background therapy
М. П. Костинов, О. А. Свитич, А. Г. Чучалин, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection
Krist Helen Antunes, Gisele Cassão, Leonardo Duarte Santos, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17

Broncho-Vaxom Attenuates Lipopolysaccharide-Induced Inflammation in a Mouse Model of Acute Lung Injury
Min Seok Woo, Dang Long Cao, Eun‐Jin Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7135-7135
Open Access | Times Cited: 3

Can bacterial lysates be useful in prevention of viral respiratory infections in childhood? The results of experimental OM-85 studies
Stefania Ballarini, Ledit Ardusso, José António Ortega Martell, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 10

Oral Bacterial Lysate OM-85: Advances in Pharmacology and Therapeutics
Lingling Zhu, Yanhong Wang, Jianhua Feng, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 4387-4399
Open Access | Times Cited: 1

The OM-85 bacterial lysate: A new tool against SARS-CoV-2?
Vadim Pivniouk, Donata Vercelli
Multidisciplinary Respiratory Medicine (2023) Vol. 18
Open Access | Times Cited: 2

Bacterial ligands in the rehabilitation of healthcare workers after COVID-19
N. O. Kryukova, N. D. Abramova, E. A. Khromova, et al.
PULMONOLOGIYA (2022) Vol. 32, Iss. 5, pp. 716-727
Open Access | Times Cited: 3

Effect of respiratory tract co-colonizers on initial attachment of Neisseria meningitidis
Poonam Kanojiya, Sunil D. Saroj
Archives of Microbiology (2023) Vol. 205, Iss. 8
Closed Access | Times Cited: 1

OM-85 reduces SARS-COV-2 viral RNA expression in nasopharyngeal cells from COVID-19 patients
Gisele Cassão, Krist Helen Antunes, João Ismael Budelon Gonçalvez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1

Brief research report: OM-85 reduces SARS-COV-2 viral RNA expression in nasopharyngeal cells from COVID-19 patients
Gisele Cassão, Krist Helen Antunes, João Ismael Budelon Gonçalvez, et al.
Frontiers in Virology (2023) Vol. 3
Open Access

Page 1

Scroll to top